Celltrion says trial shows antibody Covid-19 treatment to be safe and effective

The trials, which involved 1,315 participants, have taken place since January in 13 countries, including in South Korea, the United States, Spain and Romania, Celltrion said in a statement.

South Korean drugmaker Celltrion Inc on Monday announced positive results for its experimental antibody Covid-19 treatment that it said was safe and reduced the treatment period by nearly five days in Phase 3 global clinical trials.